- Home
- FNKO vs ELDN Comparison
FNKO vs ELDN Comparison
Compare FNKO & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- ELDN
- Stock Information
- Founded
- FNKO 2017
- ELDN 2004
- Country
- FNKO United States
- ELDN United States
- Employees
- FNKO N/A
- ELDN N/A
- Industry
- FNKO Recreational Games/Products/Toys
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- FNKO Consumer Discretionary
- ELDN Health Care
- Exchange
- FNKO Nasdaq
- ELDN Nasdaq
- Market Cap
- FNKO 170.7M
- ELDN 202.4M
- IPO Year
- FNKO 2017
- ELDN N/A
- Fundamental
- Price
- FNKO $3.31
- ELDN $2.47
- Analyst Decision
- FNKO Strong Buy
- ELDN Strong Buy
- Analyst Count
- FNKO 5
- ELDN 2
- Target Price
- FNKO $8.70
- ELDN $12.50
- AVG Volume (30 Days)
- FNKO 1.6M
- ELDN 676.8K
- Earning Date
- FNKO 11-06-2025
- ELDN 11-11-2025
- Dividend Yield
- FNKO N/A
- ELDN N/A
- EPS Growth
- FNKO N/A
- ELDN N/A
- EPS
- FNKO N/A
- ELDN 0.21
- Revenue
- FNKO $970,702,000.00
- ELDN N/A
- Revenue This Year
- FNKO N/A
- ELDN N/A
- Revenue Next Year
- FNKO $10.55
- ELDN N/A
- P/E Ratio
- FNKO N/A
- ELDN $11.41
- Revenue Growth
- FNKO N/A
- ELDN N/A
- 52 Week Low
- FNKO $2.22
- ELDN $2.38
- 52 Week High
- FNKO $14.65
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- FNKO 48.35
- ELDN 38.77
- Support Level
- FNKO $3.20
- ELDN $2.41
- Resistance Level
- FNKO $3.48
- ELDN $2.84
- Average True Range (ATR)
- FNKO 0.19
- ELDN 0.13
- MACD
- FNKO 0.05
- ELDN 0.01
- Stochastic Oscillator
- FNKO 53.53
- ELDN 12.79
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.